#Reverse Transcriptase Market Demand | Explore Tumblr posts and blogs

healthcaremarketanalysis · 1 month ago

Text

mRNA Synthesis & Manufacturing Market worth $738.3 million by 2029

The mRNA synthesis and manufacturing market is projected to reach USD 738.3 million in 2029 from USD 624.4 million in 2024. This market is projected to grow at a CAGR of 3.4% over the forecast period. The primary drivers behind the expansion of this industry are the Growing focus on mRNA-based vaccine development, expanding therapeutic applications of mRNA technology, advancements in mRNA synthesis technology, increased outsourcing for mRNA synthesis and modification, and collaborations among industry players. However, stability, storage, and manufacturing scalability present a challenge to this industry. This is further amplified by the slow patient adoption rate and the complexity of the development of mRNA-based therapy.

In many important respects, artificial intelligence (AI) is transforming the mRNA synthesis and manufacturing sector. First, by scanning large databases to find suitable mRNA sequences for therapeutic usage, artificial intelligence speeds up drug research and development greatly. Developed tools like the LinearDesign AI aim to maximize mRNA sequences, therefore producing vaccines with more antibody responses than conventional techniques. From raw material acquisition to final product packaging, artificial intelligence maximizes several manufacturing steps, thereby lowering costs and raising efficiency. AI-powered predictive maintenance reduces downtime and guarantees manufacturing equipment's seamless running.

Download PDF Brochure:

Browse in-depth TOC on "mRNA Synthesis & Manufacturing Market"

250 - Tables

50 - Figures

250 - Pages

The market is expanding rapidly due to factors such as the development of mRNA-based vaccines and expanded applications such as cancer immunotherapies. Furthermore, improvements in mRNA synthesis technology, a rise in mRNA synthesis and modification outsourcing, and industry players working together to create mRNA therapies all contribute to the growth of the mRNA synthesis and manufacturing market. Additionally, factors such as advancements in drug delivery technologies, growth in the regenerative medicines market, and increasing government funding and private investments in the mRNA therapeutics market will further provide revenue growth opportunities for the players operating in mRNA synthesis & manufacturing.

Based on product type, the mRNA synthesis and manufacturing products market is divided into two broad categories, consumables and instruments. The consumables segment of the market held the largest market share in 2023, due to the sustained use of consumables such as nucleotides, RNA polymerase, reverse transcriptase, buffer, and reagents that also require frequent repurchases. The consumables segment will be experiencing high growth due to several factors, including an increase in the mRNA therapeutics pipeline and growing investments made to develop mRNA-based therapeutics, advancement in mRNA synthesis technologies, increase in demand for consumables among contract service providers with the growing trend of outsourcing.

Based on service type, the global mRNA synthesis and manufacturing services market has been categorized into four service types: mRNA synthesis, modification, and related activities; purification of mRNA; analytical and characterization services; and scale-up and manufacture activities. In 2023, the mRNA synthesis and modification services captured the highest market share because of the demand for custom and modified mRNA sequences, which are intended to enhance therapeutic candidates for the molecules market. Given the expanding uses of the mRNA technology, researchers and developers are looking for mRNA sequences that can incorporate protein expression enhancement or immune response improvement.

Based on application, the market for mRNA synthesis and manufacturing has been divided into segments including vaccines and cell & gene therapy. The vaccine segment has the dominant share in the market in 2023. The large share of this segment can be supported by the large number of clinical trials of mRNA vaccines for various diseases infectious diseases, cancer and rare genetic disorders. The remarkable success of mRNA-based COVID-19 vaccines has not only proven the efficacy & scalability of mRNA technology but also catalysed interest in targeting other therapy areas, such as cancer and rare diseases.

Based on end user, the mRNA synthesis and manufacturing market has been categorized into pharmaceutical and biotechnology companies, academic and research institutes, and CROs and CDMOs. In 2023, pharmaceutical and biotechnology companies dominated the market for mRNA synthesis and manufacturing. According to the market's emerging needs, companies are investing to develop next-generation biologics such as mRNA therapeutics. Higher research and development activities of companies to develop mRNA therapeutics and cell and gene therapies have resulted in rising needs for specialized consumables and instruments as well as synthesis, modification, purification, analysis, and characterization services.

Request Sample Pages:

The global mRNA synthesis and manufacturing market is consolidated with the top five players— Thermo Fisher Scientific Inc. (US), Aldevron, LLC. (Danaher Corporation) (US), TriLink BioTechnologies (US), GenScript (US), and Merck KGaA (Germany). Other prominent market players include, New England Biolabs (US), Promega Corporation (US), Sartorius AG (Germany), WuXi Biologics (China), Takara Bio Inc. (Japan), GENEWIZ (Azenta US, Inc.) (US), Lonza (Switzerland), Telesis Bio Inc. (US), Aurigene Pharmaceutical Services Ltd. (Dr. Reddy's Laboratories Ltd.) (India), ST Pharm (South Korea), AGC Biologics (US).

Thermo Fisher Scientific Inc. (US):

Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, is a leading player in mRNA synthesis and manufacturing, offering a broad range of products and services tailored to this field. The company provides advanced solutions for mRNA synthesis, including custom RNA synthesis services and reagents through its GeneArt platform, which supports the development of mRNA constructs for research, therapeutic, and vaccine applications. Thermo Fisher's technologies enable efficient in vitro transcription (IVT) and include automated solutions that enhance scalability and production efficiency. Their extensive expertise, quality assurance measures, and global reach position them as a key player in advancing mRNA technology and supporting the development of next-generation therapeutics and vaccines.

Aldevron, LLC. (Danaher Corporation) (US):

Aldevron, established in 1998 and based in Fargo, North Dakota, is a key player in the nucleic acid synthesis industry, particularly known for its expertise in mRNA synthesis and manufacturing. The company is highly regarded for producing high-quality mRNA and plasmid DNA, essential for cutting-edge applications in vaccine development, gene therapy, and other biotechnological innovations. Aldevron's offerings include custom RNA synthesis and cGMP-compliant mRNA production, ensuring that their products meet the stringent standards required for clinical use. Aldevron's robust quality control and assurance processes further guarantee the reliability and efficacy of their products. As a global leader in the field, Aldevron has expanded its facilities and technological infrastructure to meet growing demand, establishing a significant presence in the biopharmaceutical sector. Their collaborations with biotechnology firms, pharmaceutical companies, and research institutions underscore their pivotal role in advancing mRNA technology and supporting the development of next-generation therapies and vaccines.

TriLink BioTechnologies (US):

TriLink BioTechnologies, a subsidiary of Maravai LifeSciences based in San Diego, California, is a key player in mRNA synthesis and manufacturing. The company excels in providing high-quality nucleic acid products and services, with a strong focus on mRNA technology. TriLink offers comprehensive mRNA synthesis services, including the production of custom mRNA and chemically modified mRNA, which enhances stability and translation efficiency—crucial for effective therapeutic and vaccine development. Utilizing advanced in vitro transcription technologies, TriLink ensures high yield and purity in their mRNA products.

For more information, Inquire Now!

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1-888-600-6441

UK +44-800-368-9399

Email: [email protected]

Visit Our Website: https://www.marketsandmarkets.com/

#mRNA Synthesis & Manufacturing Market

0 notes

credenceresearchdotblog · 4 months ago

Text

The Specialty Enzymes Market is projected to grow from USD 6,142.34 million in 2023 to an estimated USD 10,644.70 million by 2032, at a compound annual growth rate (CAGR) of 6.30% from 2024 to 2032. The specialty enzymes market has emerged as a rapidly expanding segment in the biotechnology industry, driven by growing demand in various sectors such as pharmaceuticals, food & beverages, diagnostics, and biotechnology research. These enzymes, which are customized for specific industrial applications, offer precision, efficiency, and enhanced specificity compared to traditional enzymes, making them indispensable in both industrial and clinical settings. The market is projected to grow significantly in the coming years, owing to the increasing need for innovative and efficient solutions in complex biotechnological processes.

Browse the full report at https://www.credenceresearch.com/report/specialty-enzymes-market

Market Overview

Specialty enzymes are proteins that catalyze chemical reactions in living organisms, and their role in industrial applications has evolved significantly. Unlike bulk enzymes, which are used in high quantities for processes like detergent manufacturing or biofuel production, specialty enzymes are produced and used in smaller amounts but are designed for more specialized, high-value applications. They are tailored to perform specific functions, which are often critical in processes such as disease diagnosis, drug formulation, or food processing.

The global specialty enzymes market is anticipated to grow at a compound annual growth rate (CAGR) of over 7% between 2024 and 2030, reaching a market size of more than $8 billion by the end of this period. This growth is attributed to advancements in enzyme engineering, a rise in the use of enzymes in pharmaceutical and biotechnology sectors, and an increased awareness of sustainable and eco-friendly industrial processes.

Key Market Drivers

1. Rising Demand in Pharmaceuticals and Diagnostics: One of the primary drivers of the specialty enzymes market is the increasing use of these enzymes in pharmaceutical applications, especially in drug development and production. Enzymes like proteases, lipases, and polymerases are widely used in the synthesis of therapeutic proteins, antibiotics, and other pharmaceutical products. Additionally, specialty enzymes are critical components in diagnostic kits and molecular diagnostics, including COVID-19 testing, where enzymes like reverse transcriptase play a key role.

2. Innovation in Biotechnology: The rapid progress in enzyme technology, such as protein engineering and recombinant DNA technology, has led to the development of highly specific and efficient specialty enzymes. These innovations have significantly improved the production processes in industries like biofuels, agriculture, and food processing. For example, in the food and beverage industry, specialty enzymes are used to improve product quality, enhance flavors, and extend shelf life, all while reducing environmental impact.

3. Increased Demand for Sustainable Solutions: As industries worldwide focus on reducing their environmental footprint, the demand for green and sustainable processes has risen sharply. Specialty enzymes offer eco-friendly alternatives to chemical catalysts, reducing the use of harsh chemicals and energy in industrial processes. In the textile industry, for instance, enzymes are used for fabric softening, bleaching, and desizing, eliminating the need for toxic chemicals and saving water.

4. Growing Research and Development in Biocatalysis: Biocatalysis, the process of using natural catalysts such as enzymes to perform chemical transformations, is gaining momentum in pharmaceutical and chemical industries. Specialty enzymes serve as biocatalysts in producing enantiomerically pure compounds, which are essential in the development of active pharmaceutical ingredients (APIs). This trend is further supported by the increasing investment in research and development (R&D) activities by biotech companies, aimed at discovering new enzymes with enhanced functionalities.

Challenges Facing the Market

Despite its promising growth, the specialty enzymes market faces several challenges. One major hurdle is the high cost of enzyme production and purification, which limits their use in certain applications. The complex nature of enzyme engineering and the need for specific conditions (such as temperature and pH) for optimal enzyme activity can also pose difficulties. Additionally, regulatory challenges and patent issues could slow down the introduction of new enzyme products to the market.

Key Players and Competitive Landscape

The specialty enzymes market is highly competitive, with several prominent companies driving innovation and market growth. Key players include Novozymes, DuPont, BASF, DSM, and Roche, among others. These companies are investing heavily in R&D, mergers, acquisitions, and strategic collaborations to expand their product portfolios and maintain a competitive edge. Startups and smaller firms are also entering the market, offering innovative solutions to niche problems in industries like agriculture and bioenergy.

Future Outlook

The future of the specialty enzymes market looks bright, with continuous advancements in biotechnology and increased awareness of the benefits of enzyme-based solutions. As the demand for personalized medicine grows, especially in the pharmaceutical industry, specialty enzymes will play an even more significant role in developing targeted therapies. Furthermore, the growing trend towards sustainability in industries like food and beverages, textiles, and bioenergy will provide additional growth opportunities for this market.

Key players

Brain Biotech AG

Novozymes A/S

Codexis Inc.

Sanofi

Merck KGaA

Dyadic International Inc.

Advanced Enzyme Technologies

Amano Enzyme Inc.

Hoffmann-La Roche Ltd.

New England Biolabs

BBI Solutions

Creative Enzymes

Biostatical

Sekisui Diagnostics

Segments

Based on type

Carbohydrase

Amylases

Cellulases

Others

Proteases

Lipases

Polymerases & Nucleases

Others

Based on application

Pharmaceuticals

Research & Biotechnology

Diagnostics ,

Biocatalysts

Others

Based on form

Liquid

Dry

Based on source

Microorganisms

Plants

Animals

Based on region

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/specialty-enzymes-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

businessmarketreports · 6 months ago

Text

The Evolution of the COVID-19 Test Devices Market: From Early Pandemic to Present Day

The COVID-19 pandemic triggered a rapid and unprecedented surge in demand for diagnostic testing devices. As the pandemic unfolded, the market for COVID-19 tests underwent a remarkable transformation, characterized by rapid innovation, technological advancements, and increased global production capacity.

Buy the Full Report for More Insights on the COVID-19 Tests Market Forecast, Download a Free Sample Report

Early Pandemic: A Rush for Testing Devices

Initial Shortages: The early stages of the pandemic were marked by severe shortages of testing devices, particularly in regions with high infection rates. This scarcity hindered efforts to contain the virus and understand its spread.

Rapid Innovation: In response to the urgent need, manufacturers, researchers, and governments worldwide accelerated the development of new testing technologies, including RT-PCR, antigen tests, and rapid point-of-care (POC) tests.

Scaling Up Production: Global efforts were made to scale up the production of testing devices, leveraging existing manufacturing capabilities and establishing new facilities.

Advancements in Testing Technologies

RT-PCR Tests: Reverse-transcriptase polymerase chain reaction (RT-PCR) tests remained the gold standard for COVID-19 diagnosis, offering high sensitivity and specificity. However, their complexity and turnaround time limited their widespread use.

Antigen Tests: Rapid antigen tests, while less sensitive than RT-PCR, provided faster results and were more suitable for mass testing and screening purposes.

Point-of-Care Tests: POC tests, often lateral flow immunoassays, offered rapid results at the point of care but faced challenges in terms of sensitivity and specificity.

Saliva-Based Tests: The development of saliva-based testing simplified sample collection and made testing more accessible to the general public.

Market Expansion and Competition

Increased Production Capacity: Global manufacturers expanded their production capacities to meet the surging demand for COVID-19 tests.

New Market Entrants: Many new companies entered the market, driven by the lucrative opportunities presented by the pandemic.

Intense Competition: The market became highly competitive, with manufacturers vying for market share through price reductions, technological advancements, and improved turnaround times.

Challenges and Future Trends

Variant Challenges: The emergence of new COVID-19 variants, such as Omicron, posed challenges for testing devices, requiring adaptations to maintain accuracy.

Long-Term Demand: As the pandemic evolves, the long-term demand for COVID-19 tests remains uncertain, potentially impacting market dynamics.

Dual-Use Technologies: Some testing technologies, particularly those developed for COVID-19, have the potential to be repurposed for other infectious diseases, creating new market opportunities.

Home Testing: The increasing availability of at-home COVID-19 tests is changing the landscape of testing, empowering individuals to take control of their health.

The COVID-19 pandemic has significantly transformed the testing devices market, driving rapid innovation, increased production capacity, and a surge in demand. As the pandemic evolves, the market is likely to continue adapting to new challenges and opportunities, shaping the future of infectious disease testing.

#COVID-19 Test Devices Market

0 notes

priyanshisingh · 1 year ago

Text

Molecular Biology Enzymes Kits and Reagents Market Size, A Forecasted Outlook for 2023-2030

The latest market report published by Credence Research, Inc. “Global Molecular Biology Enzymes Kits and Reagents Market: Growth, Future Prospects, and Competitive Analysis, 2022 – 2030. The global demand for molecular biology enzymes kits and reagents market was valued at USD 20.2 Billion in 2022 and is expected to reach USD 38.12854245 Billion in 2030, growing at a CAGR of 9.50% between 2023 and 2030.

Molecular Biology Enzymes Kits and Reagents Market encompasses an extensive range of products crucial for various molecular biology protocols, research, and clinical applications. This market segment includes enzymes such as DNA and RNA polymerases, reverse transcriptases, restriction endonucleases, ligases, and various modifying enzymes, among others. These enzymes play pivotal roles in procedures like PCR, qPCR, sequencing, cloning, cDNA synthesis, and restriction digestion. Accompanying these enzymes are specialized reagents and kits optimized for specific applications, ensuring accuracy, reproducibility, and high yield. The demand in this market has been amplified due to the burgeoning biotechnology and pharmaceutical sectors, ongoing research in genetics and molecular biology, and the rising prevalence of infectious diseases and genetic disorders.

Additionally, the recent surge in genomic studies and personalized medicine has further propelled the requirement for high-quality enzymes and associated reagents. Major players in this space are continuously investing in R&D to offer innovative, efficient, and cost-effective solutions. However, the market's growth can be constrained by factors like high costs of certain products and stringent regulatory landscapes. Overall, the Molecular Biology Enzymes Kits and Reagents Market represents a dynamic and vital segment in the life sciences industry, with its products underpinning many modern biological and clinical breakthroughs.

Molecular Biology Enzymes Kits and Reagents Market Key Growth Trends have been a subject of great interest and significance in the scientific community. These trends highlight the constant evolution and advancements in molecular biology research, particularly in relation to enzymes, kits, and reagents. Researchers are continually seeking innovative solutions to optimize experimental procedures and improve efficiency. The market offers a wide range of enzymatic products that cater to diverse applications such as DNA amplification, sequencing, cloning, gene expression analysis, and protein purification. These growth trends indicate an increasing demand for user-friendly enzyme kits that provide reliable results with minimal effort. Furthermore, there is a growing emphasis on environmentally friendly products that reduce waste generation while maintaining high performance standards.

Molecular Biology Enzymes Kits and Reagents Market Key Offerings-

1. Enzymes

DNA Polymerases: Essential for PCR, qPCR, and sequencing applications.

RNA Polymerases: Used for in vitro transcription processes.

Reverse Transcriptases: Central to cDNA synthesis and RT-PCR.

Restriction Endonucleases: Enable DNA fragment analysis and cloning.

Ligases: Vital for linking DNA fragments together.

Modifying Enzymes: Such as methyltransferases and phosphatases, crucial for modifying DNA molecules.

2. Kits

PCR and qPCR Kits: Contain all necessary reagents for amplifying DNA or RNA.

cDNA Synthesis Kits: Offer reagents for synthesizing complementary DNA from RNA templates.

DNA Sequencing Kits: Provide the necessary components for DNA sequencing procedures.

Cloning Kits: Simplify the process of inserting DNA into vectors for expression or analysis.

Genotyping Kits: Facilitate the identification of genetic variations.

3. Reagents

Nucleotides: Basic building blocks for DNA and RNA synthesis.

Primers and Probes: Short strands of nucleic acids essential for processes like PCR.

Buffers and Solutions: Maintain optimal conditions for enzymatic reactions.

Dyes and Stains: Enable visualization of nucleic acids.

4. Sample Preparation Products

DNA and RNA Extraction and Purification Kits: Help in isolating nucleic acids from various samples.

Gel Extraction Kits: Allow for the purification of DNA fragments from agarose gels.

5. Assay Kits

Gene Expression Assays: Facilitate the study of gene activity.

Mutation Detection Assays: Enable the identification of genetic mutations.

Methylated DNA Detection Kits: Used to study DNA methylation patterns.

6. Library Preparation Kits

Essential for next-generation sequencing, these kits provide tools to create libraries from DNA or RNA samples for sequencing applications.

7. Accessory Products

Positive Controls: Provide known references for various assays.

Stabilizers and Preservatives: Extend the shelf-life of enzymes and other sensitive products.

Browse 250 pages report Molecular Biology Enzymes Kits and Reagents Market By Product (Kits & Reagents, Enzymes, Ligases, Restriction Endonucleases, Reverse Transcriptases, Other Enzymes) By Applications (PCR, Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology, Other) - Growth, Future Prospects & Competitive Analysis, 2016 – 2030)- https://www.credenceresearch.com/report/molecular-biology-enzymes-kits-and-reagents-market

Molecular Biology Enzymes Kits and Reagents Market Regional Analysis-

1. North America:

Status: Dominates the global market in terms of revenue.

Drivers: Robust biotechnological and pharmaceutical sectors, extensive R&D activities, advanced healthcare infrastructure, and the presence of key market players.

Key Countries: The United States, owing to its heavy investments in biopharmaceutical research and genomics, is a significant contributor.

2. Europe:

Status: Second-largest market after North America.

Drivers: Strong academic and research base, especially in countries like Germany and the UK, paired with substantial public and private funding.

Key Countries: Germany, UK, France, and Switzerland, with their rich history in pharmaceuticals and biotechnology research.

3. Asia-Pacific (APAC):

Status: Fastest-growing region in the market.

Drivers: Rapidly developing biotechnology sectors in countries like China and India, coupled with increasing government funding in healthcare and research. The region's large population also drives clinical research and diagnostics, necessitating molecular biology products.

Key Countries: China, India, Japan, and South Korea.

4. Latin America:

Status: Moderate growth compared to other regions.

Drivers: Gradual growth in biotechnology and healthcare sectors, increasing public awareness, and rising government investments in research.

Key Countries: Brazil and Mexico are the leading contributors due to their sizable pharmaceutical and biotech industries.

5. Middle East & Africa (MEA):

Status: Smaller market share but shows potential for growth.

Drivers: Increasing investments in healthcare and research, especially in affluent nations like the UAE and Saudi Arabia.

Key Countries: South Africa, UAE, and Saudi Arabia. South Africa, in particular, has shown significant strides in healthcare research.

Molecular Biology Enzymes Kits and Reagents Market Future Outlook-

The future of the Molecular Biology Enzymes Kits and Reagents Market is anticipated to be vibrant and dynamic, underpinned by a series of technological breakthroughs and evolving healthcare paradigms. As the world increasingly leans towards personalized medicine, the demand for molecular tools that facilitate precise genetic and genomic analyses is expected to surge. Additionally, the rising prevalence of chronic diseases and global health crises, such as pandemics, further emphasize the importance of molecular diagnostics and research, consequently bolstering the market. Technological advancements, especially in areas like next-generation sequencing, CRISPR-Cas genome editing, and single-cell analysis, will likely shape the market's landscape, opening new avenues for diagnostics and therapeutic interventions.

Moreover, emerging economies are set to play a pivotal role, with their escalating healthcare investments and burgeoning biotech sectors. However, the market isn't without challenges. Regulatory complexities, high costs of advanced solutions, and ethical considerations in areas like gene editing will require navigation. Collaborations, innovations, and strategic mergers will be key for market players to thrive. In essence, the Molecular Biology Enzymes Kits and Reagents Market is on the precipice of significant growth, poised to make monumental contributions to science and medicine.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Molecular Biology Enzymes Kits and Reagents Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Molecular Biology Enzymes Kits and Reagents Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/molecular-biology-enzymes-kits-and-reagents-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/cannabinoid-biosynthesis-market

Related Report: https://www.credenceresearch.com/report/oncology-molecular-diagnostics-market

Browse Our Blog: https://www.linkedin.com/pulse/molecular-biology-enzymes-kits-reagents-market-share-demand-singh

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

0 notes

bigfandeer · 4 years ago

Text

Global Antiviral Drugs Market 2021 | Global Opportunity Analysis and Industry Forecast, 2018-2022

Overview The anti-viral drugs market companies is anticipated to grow by US$62.67 by 2022 rapidly growing at a CAGR of 6.9% during the forecast period. The global anti-viral drugs market is driven by rise in healthcare expenditure and emergence of life-threatening diseases. These factors have helped shape the anti-viral drugs market and are expected to boost the growth. Companies in the anti-viral drugs market could also face challenges such as lack of awareness and shortage of skilled professionals. The details covered in the anti-viral drugs market report cover all the aspects of the industry. Anti-viral drugs market analysts have also shared growth projections in the report and have suggested anti-viral drugs market players to plan growth strategies accordingly.

Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2454

Segmentation

The global anti-viral drugs market has been segmented based on application and mechanism of action. By application, the market has been segmented into hepatitis, HIV/AIDS, herpes, influenza and others. By mechanism of action, the market has been segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors, and others.

Regional Analysis

The Americas, Europe, Asia Pacific, and Middle East & Africa are the key markets for antiviral drugs. The Americas is the largest market followed by Europe. Growing prevalence of viral infections in the region, the presence of key players in the region and high healthcare expenditure drives the market in the Americas.

The Europe market is driven by the presence of a robust healthcare sector and high investment in R&D activities.

Asia Pacific is slated to be the fastest growing market for anti-viral drugs. Growing prevalence of viral infections in the developing economies of the region coupled with the outlay of massive amounts on healthcare facilities supports the growth of the Asia Pacific market.

Competitive Landscape

The anti-viral drugs market is supported by growing research and development investment. The population growth around the world and increasing demand of anti-viral drugs market based services and products also support the market growth. However, changes in policies and lack of clarity in guidelines can affect the market growth. The report covers all such details which will help companies in the anti-viral drugs market to strengthen their business plan and improve their product portfolio. The anti-viral drugs market research report also provides company profiles of major companies. The company profiles of many organizations operating in the anti-viral drugs market report highlights crucial details like company size, revenue growth, and details of mergers and acquisitions taking place in the anti-viral drugs market. New companies and established businesses can plan their strategies based on this data provided in the anti-viral drugs market research report.

Industry News

NeuroBo Pharmaceuticals, a biotechnology firm, has announced that it has purchased ANA Therapeutics, a privately owned biotechnology company that produces a patented niclosamide capsule formulation for the indication of coronavirus, now in Phase 2/3 clinical trials as a cure for COVID-19. The deal was unanimously approved by both the Boards of Directors of NeuroBo Pharmaceuticals and ANA Therapeutics

Table of Contents

1 Introduction

1.1 Definition

1.2 Scope of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

4.1 Porter’s five forces model

4.1.1 Bargaining Power of suppliers

4.1.2 Bargaining Power of Customer

4.1.3 Intensity of Competitor’s

4.1.4 Threat of New Entrants

5 Global Anti-Viral Drugs Market, by Application

5.1 Introduction

5.1.1 Hepatitis

5.1.2 HIV/AIDS

5.1.3 Herpes

5.1.4 Influenza

5.1.5 Others

Browse Complete Report @ https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half- Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: [email protected]

#Anti-viral drugs market 2021 #Anti-viral drugs market Growth Factors #Anti-viral drugs market report #Anti-viral drugs market share #Anti-v

1 note · View note

rachel01-zane · 5 years ago

Text

Reverse Transcriptase Market Trends, Opportunities, Revenue and Region Analysis, Forecast 2019-2026

Chicago, United States, Dec 06, 2019 —Report Hive Research adds Reverse Transcriptase Market report to its research database. The report delivers in depth market statistics and elaborates on different market segments categorized by players, end users, applications at the regional level individually. Citing each and every challenge obstructing the market growth, the Reverse Transcriptase market…

View On WordPress

0 notes

kenresearchcompany · 2 years ago

Text

Global Immunoassays Market is expected to record a positive CAGR of ~6% during the forecast period 2022-2028: Ken Research

Immunoassays are bioanalytical techniques that use the precision of an antigen-antibody reaction to detect and quantify analytes in biological samples such as urine, blood, saliva, tissues, and cells. Clinical diagnostics, drug discovery, environmental monitoring, biopharmaceutical analysis, drug monitoring, and food testing are all common applications for such techniques. In addition, they generally exhibit quick and precise outcomes, allowing a clinician to diagnose a variety of diseases such as diabetes, cancer, and heart disease accurately.

The Global Immunoassays Market is expected to record a positive CAGR of ~6% during the forecast period (2022-2028) and reach a revenue of ~US$ 60 Bn by 2028, due to the rising prevalence of chronic and infectious diseases. The ongoing Covid-19 pandemic has accelerated the use of immune-diagnostics assays for correct diagnosis and containment of the Covid-19 pandemic. In addition, immunoassay tests are highlighted as an important diagnostic method as they enable reliable and affordable detection of viruses and bacteria. Such tests are used to detect both acute and chronic diseases.

For more information, request a free sample @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTkyNDkz

The rising prevalence of chronic, and infectious diseases, including COVID-19, HIV/AIDS, dengue, foodborne disease, and other diseases is one of the major factors propelling the immunoassays market growth.

In addition, the cost-effectiveness and higher efficiency of immunoassay tests also make a significant contribution to their growth.

For instance, the WHO Pan American Health Organization (PAHO) reported 21,41,240 dengue cases in the Americas, including 10,53,420 confirmed cases and 927 associated deaths, as of August 2022. In addition, Brazil (19,10,657), Peru (57,469), Colombia (38,844), Nicaragua (37,369), and Ecuador have reported the most cases (12,645) during the same period.

In addition, according to the study conducted in 2021 by Food Security Cluster, an Italian non-profit organization that outlines food availability, access, and utilization issues, more than 600 million individuals (one in ten) globally, become ill with the foodborne disease each year, and 420,000 die.

Technical challenges with immunoassay kits/reagents and instruments are likely to impede the market growth.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak had been proclaimed a public health emergency in late January 2020, medical professionals and scientists experienced the necessity for extensive and rapid testing of individuals to implement measures to contain the virus's spread. Additionally, real-time PCR (RTPCR) tests and antibody/antigen tests have erupted as vital tools for the global healthcare system in managing the outbreak.

Key Trends by Market Segment

By Product Type: Reagents & Kits hold the largest share of the Global Immunoassays Market in 2021.

Reagents/kits are a preferable type of product for immunoassay testing as they offer a quick, simple, and cost-effective method of detection with accuracy and specificity considerably better (in some cases) than other methods.

The global outbreak of Covid-19 has prompted governments to impose critical measures to prevent its spread, which focus primarily on accurate and prompt identification of virus-infected individuals using the most precise and sensitive method available, notably real-time reverse transcriptase PCR (RT-PCR). This has raised the global demand for detection kits.

For more information, request a free sample @ https://www.kenresearch.com/ask-customization.php?Frmdetails=NTkyNDkz

By Application: The infectious disease segment held the largest market share in 2021.

The rising global prevalence rate of infectious diseases such as HIV/AIDS, malaria, dengue fever, influenza, and Covid-19 is one of the major factors driving the demand for immunoassays tests for infectious diseases.

For instance, according to the world health organization (WHO), influenza leads to around 3 to 5 million serious cases and 250,000 to 500,000 deaths worldwide every year.

The growing number of cancer cases worldwide is also a significant contributor to the expansion of the immunoassay market during the forecast period.

For instance, according to the American Cancer Society, cancer continues to be the second leading cause of death in the U.S., after cardiovascular disease. In 2022, the U.S. is expected to see 1.9 million new cancer cases and 609,360 cancer deaths, for a total of 1,670 deaths per day.

By Technology: The Enzyme Immunoassays (EIA)/Enzyme-linked immunosorbent assays (ELISA) technology segment dominated the market for immunoassays in 2021.

This technology's accuracy and ability to provide quick results is a major driving factor. In addition, ELISA's simple procedure, high specificity and sensitivity, cost-effectiveness, and high efficiency are all contributing factors to its growth.

Furthermore, the use of ELISA/EIA for antigen/antibody detection is among the most commonly available diagnostic tools, and it is extensively used for diagnosing swine influenza as well.

According to the National Library of Medicine (NLM), operated by the U.S. federal government, ELISA, indirect fluorescence antibody (IFA), and virus neutralizing assays are used to detect porcine parainfluenza virus type-1 (PPIV-1) antibody in swine serum.

By End User: The Hospitals & Clinics segment account for the majority share of the Global Immunoassays Market in 2021.

The continuous development in the healthcare industry across countries has raised the requirement for hospitals with advanced techniques and facilities.

The growing number of infectious diseases tested during the assessments and processing of body fluids, particularly following the worldwide explosion of the Covid-19 pandemic, are other major factors influencing the demand for immunoassays tests in hospitals and clinics.

By Geography: North America accounts for the largest share among all Regions within the total Immunoassays market in 2021.

Increased technological adoption in diagnostic techniques, extensive research initiatives, and increasing government funding for point-of-care testing and regulatory science activities across the healthcare industry are all contributing factors to the growth of Immunoassays in North America.

For instance, in November 2021, the U.S. Department of Health and Human Services (HHS) announced a USD 650 million investment to enhance manufacturing capacity for fast, high-quality diagnostic testing via rapid point-of-care molecular tests that help in the detection of influenza, respiratory syncytial virus (RSV), and a cluster of respiratory viruses.

In October 2020, the National Institutes of Health announced the third round of contract awards for the intensity and manufacturing of new COVID-19 testing technologies in collaborative efforts with the Biomedical Advanced Research and Development Authority (BARDA), a U.S. Department of Health and Human Services.

Additionally, the six new rapid acceleration of diagnostics (RADx) initiative contracts comprise USD 98.35 million for point-of-care and other novel testing techniques that provide modes of sample collection, processing, and output. Inclusion with smart devices, digital processing that can be deployed to COVID-19 hot spots, and test results readily accessible in minutes are among the advancements in such new techniques.

The Asia Pacific region is expected to grow at the fastest CAGR during the forecasted period 2022-2028, owing to the government's increased emphasis on improving healthcare infrastructure, the adoption of innovative laboratory techniques and procedures, such as blotting technique, and gel electrophoresis for quicker and more efficient examination and diagnosis of infectious and chronic diseases, and growing preference for diagnostic reagents.

To more regional trends, Ask for a Customization @ https://www.kenresearch.com/sample-report.php?Frmdetails=NTkyNDkz

Competitive Landscape

The Global Immunoassays market is highly competitive with ~500 players which include globally diversified players, regional players as well as a large number of country-niche players each with their niche bioanalytical setting such as clinical diagnostics, biopharmaceutical analysis, environmental monitoring, security, and food testing, and others, for end-users. The immunoassays market's growth is heavily reliant on detection technologies and advancements in testing equipment and instruments.

Country-Niche players constitute about ~75% of the competitors, while regional players constitute about ~20%. Some of the major players in the market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, PerkinElmer, Quidel Corporation, Ortho Clinical Diagnostics Holdings, Sysmex Corporation, DiaSorin S.p.A. and among others.

Recent Developments Related to Major Players and Organizations

In February 2022, Siemens Healthineers, a German healthcare company, launched Enhanced Liver Fibrosis (ELF) Test in the U.S., offering broad clinical access to the nonsurgical diagnostic tool. In addition, the Food and Drug Administration (FDA) granted De Novo marketing authorization for the test.

In July 2021, Roche, a Swiss pharmaceutical company, announced the launch of its new Elecsys Epstein-Barr virus (EBV) immunoassay panel, which includes the Elecsys EBV IgM, EBV VCA IgG, and EBV EBNA IgG immunoassays and detects Epstein-Barr virus antibodies at various infection stages.

In April 2021, DiaSorin, an Italian Biotechnology company, launched its new immunodiagnostic Point-of-Care (POC) reader 'LIAISON IQ' and the 'LIAISON Quick Detect Covid TrimericS Ab' test. The LIAISON IQ's test detects specific IgG antibodies against SARS-CoV-2 Spike Protein in human blood capillaries from a throat swab in 10 minutes.

In February 2021, Thermo Fisher Scientific Inc., a U.S.-based manufacturer of analytical laboratory instruments, announced a partnership with Mindray, a Chinese medical device company, to make two clinical chemistry analyzers available to customers in the United States (U.S.) and Canada for drug of abuse testing.

In April 2020, Bio-Rad Laboratories, a U.S.-based manufacturer of specialized technological products for the life science research and clinical diagnostics markets, announced the release of a blood-based immunoassay kit to detect antibodies to the coronavirus SARS-CoV-2, the virus associated with COVID-19.

Conclusion

The Global Immunoassays Market is forecasted to continue steady growth that is witnessed since 2017. The market is primarily driven by the rising prevalence of chronic, and infectious diseases, including COVID-19. Though the market is highly competitive with over ~500 participants, few global players control the dominant share and regional players also hold a significant share.

Note: This is an upcoming/planned report, so the figures quoted here for market size estimate, forecast, growth, segment share and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients and report delivered within maximum 2 working weeks.

Market Taxonomy

The Global Immunoassays Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 is segmented by Product Types, Application, Technology, and End-User. In addition, the report also covers the market size for each of the five regions' immunoassays markets. The revenue used to size and forecast the market for each segment is USD billion.

By Type

Reagents & Kits

Analyzers/Instruments

Software & Services

By Application

Cardiology

Oncology

Autoimmune Diseases

Infectious Diseases

Others

By Technology

Radio immunoassay (RIA)

Enzyme Immunoassays (EIA) or Enzyme-linked immunosorbent assays (ELISA)

Fluoro Immunoassay (FIA)

Chemiluminescence Immunoassay (CLIA)

Others

By End User

Hospital & Clinics

Clinical Laboratories

Pharmaceuticals & Biotech Companies

Blood Banks

Academic Research Centers

Others

By Geography

North America (U.S., Canada, Mexico)

Europe (Germany, UK, France, Italy, Spain, Rest of Europe)

Asia Pacific (China, Japan, India, Australia, South Korea, Rest of Asia Pacific)

Latin America, Middle East and Africa

0 notes

market-research-repoert · 2 years ago

Text

This can help them identify opportunities and potential threats, so they can prepare for the present and future. MRI Research helps organizations to figure out whats happening in a given industry, including demand and supply statistics, degree of competition, state of competition with other emerging industries, future prospects considering technological changes, and external factors on the industry.

0 notes

research-news · 3 years ago

Text

Anti-Viral Therapies Market Trends, Size, Segments, Emerging Technologies 2028

Market Overview:

According to our new market research study on “Anti-Viral Therapies Market to 2027 - Global Analysis and Forecast - by Type, Mechanism of Action, and End User,” the market is expected to reach US$ 76,282.63 million by 2027 from US$ 40,589.79 million in 2019; it is estimated to grow at a CAGR of 8.3% from 2020 to 2027. The report highlights trends prevailing in the global anti - viral therapies market and the drivers and restraints pertaining to the market growth.

Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00012650/

Based on type, the global anti - viral therapies market is segmented into generic drugs and branded drugs. The generic drugs segment is estimated to register a higher CAGR in the market during 2020–2027. Rising demand for low-cost drugs, growing number of FDA-approved generic drugs, rising adoption in emerging nations, and patent expiry of various branded products are the factors boosting the market for the generic drugs segment.

The Report Segments Global Anti - Viral Therapies Market as Follows:

By Type

Generic Drugs

Branded Drugs

By Mechanism of Action

Nucleotide Polymerase Inhibitors

Reverse Transcriptase Inhibitors

Protease Inhibitors

Others

By Application

HIV

Hepatitis

Herpes

Virus Influenza

Other Applications

By Geography

North America

Canada

Mexico

Europe

France

Germany

Spain

Italy

Asia Pacific (APAC)

China

India

Japan

Australia

South Korea

Middle East and Africa (MEA)

Saudi Arabia

UAE

South Africa

South and Central America (SCAM)

Brazil

Argentina

Buy Now: https://www.theinsightpartners.com/buy/TIPRE00012650/

AbbVie Inc.; Abbott; Astrazeneca; F. Hoffmann-La Roche Ltd; Bristol-Myers Squibb Company; Johnson & Johnson Services, Inc.; Merck & Co., Inc.; Gilead Sciences, Inc.; GlaxoSmithKline plc; and Aurobindo Pharma are among the leading companies operating in the anti - viral therapies market.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi

E-mail: [email protected]

Phone: +1-646-491-9876

#Anti-Viral Therapies Market

0 notes

healthcaremarketanalysis · 2 months ago

Text

mRNA Synthesis & Manufacturing Market worth $738.3 million by 2029

Download PDF Brochure:

Browse in-depth TOC on "mRNA Synthesis & Manufacturing Market"

250 - Tables

50 - Figures

250 - Pages

Request Sample Pages:

Thermo Fisher Scientific Inc. (US):

Aldevron, LLC. (Danaher Corporation) (US):

TriLink BioTechnologies (US):

For more information, Inquire Now!

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

Contact:

Mr. Rohan Salgarkar

MarketsandMarkets Inc.

1615 South Congress Ave.

Suite 103, Delray Beach, FL 33445

USA : 1-888-600-6441

UK +44-800-368-9399

Email: [email protected]

Visit Our Website: https://www.marketsandmarkets.com/

#mRNA Synthesis & Manufacturing Market

0 notes

herbalmedicine12 · 3 years ago

Text

Nucleic Acid Amplification Detection and Diagnostics Market to Witness Remarkable Growth by 2027

Nucleic acid amplification technologies are used for the rapid and accurate diagnosis of chronic and infectious diseases. The nucleic acid amplification is one of the important tool for wide aspects of life science technologies including, clinical medicine development, diagnosis of infectious diseases, and gene cloning. Extensively increasing prevalence of chronic as well as infectious diseases is boosting the demand for state-of-the-art diagnostic systems. The nucleic acid amplification, detection, and diagnostics market is expected to witness a significant growth due to increasing prevalence of infectious diseases and rising demand for advanced diagnostic systems. However, lack of adequate infrastructure in emerging countries is estimated to hamper the growth of the market during the forecast period.

The growth of the nucleic acid amplification, detection, and diagnostics market is attributed to the factors such as increasing prevalence of chronic conditions and increasing demand for accurate and modern diagnostic measures. However, lack of expertise and inadequate infrastructure in emerging countries is likely to restraint the growth of the market during the forecast period.

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis – https://www.theinsightpartners.com/sample/TIPRE00016305/

Leading Nucleic Acid Amplification Detection and Diagnostics Market Players:

bioMerieux SA

BIO-RAD LABORATORIES INC.

THERMO FISHER SCIENTIFIC INC.

Illumina, Inc.

Danaher

QIAGEN

Abbott

Meridian Bioscience, Inc.

F. Hoffmann-La Roche Ltd.

The report segments Global Nucleic Acid Amplification, Detection, and Diagnostics Market as follows:

By Nucleic Acid

· Deoxyribonucleic Acid (DNA)

· Ribonucleic Acid (RNA)

By Process

· Diagnostics

· Amplification

o Transcription-Mediated Amplification (TMA)

o Loop-Mediated Isothermal Amplification (LMIA)

o Strand Displacement Amplification (SDA)

o Helicase-Dependent Amplification (HDA)

o Nucleic Acid Sequence-Based Amplification (NASBA)

o Others

· Detection

By Product Type

· Kits and Reagents

· Assays

· Systems

By Technology

· Polymerase Chain Reaction (PCR)

o Quantitative PCR (qPCR)

o Reverse-Transcriptase (RT–PCR)

o Multiplex PCR

o Nested PCR

o In-situ PCR

o Others

Nucleic Acid-Based Insights

Based on nucleic acid, the nucleic acid amplification, detection, and diagnostics market is segmented into deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). In 2019, the deoxyribonucleic acid (DNA) segment held the largest share of the market; also, the same segment is likely to witness the fastest growth during the forecast period.

Process-Based Insights

Based on process, the nucleic acid amplification, detection, and diagnostics market is segmented into diagnostics, amplification, and detection. The amplification segment is further sub-segmented as transcription-mediated amplification (TMA), loop-mediated isothermal amplification (LMIA), strand displacement amplification (SDA), helicase-dependent amplification (HDA), nucleic acid sequence-based amplification (NASBA), and others. The diagnostics segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

Product Type-Based Insights

Based on product type, the nucleic acid amplification, detection, and diagnostics market is segmented into kits & reagents, assays, and systems. The kits & reagents segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

Technology-Based Insights

Based on technology, the nucleic acid amplification, detection, and diagnostics market is segmented into polymerase chain reaction (PCR), next generation sequencing (NGS), isothermal amplification technology, direct nucleic acid detection, and CRISPR-Cas9. The polymerase chain reaction (PCR) segment is further sub-segmented as Quantitative PCR (qPCR), reverse-transcriptase (RT–PCR), multiplex PCR, nested PCR, in-situ PCR, and others. In addition, isothermal amplification technology segment is sub-segmented as target amplification systems, probe amplification systems, and signal amplification systems. Direct nucleic acid detection segment is further sub-segmented as aptamers, DNA biosensors, and others. The polymerase chain reaction (PCR) segment held the largest share of the market in 2019 and is estimated to register the fastest growth during the forecast period.

Application-Based Insights

Based on application, the nucleic acid amplification, detection, and diagnostics market is segmented into infectious diseases, genetic diseases, oncology, forensic testing, paternity testing, and others. The infectious diseases segment held the largest share of the market in 2019; whereas, oncology segment is estimated to register the fastest growth during the forecast period.

Immediate delivery of our off-the-shelf reports and pre booking of upcoming studies, through flexible and convenient payment methods – https://www.theinsightpartners.com/buy/TIPRE00016305/

Nucleic Acid Amplification Detection and Diagnostics Market Segmented by Region/Country: North America, Europe, Asia Pacific, Middle East & Africa, and Central & South America

About Us:

If you have any queries about this report or if you would like further information, please

Contact Person: Sameer Joshi

E-mail: [email protected]

Phone: +1-646-491-9876

1 note · View note

healthcaremreports · 3 years ago

Text

HIV Drugs Market Key Players, Industry Overview, Application and Forecast Analysis to 2022-2030

A recent market research report added to repository of Healthcare Market Reports is an in-depth analysis of global HIV Drugs market. On the basis of historic growth analysis and current scenario of HIV Drugs market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global HIV Drugs market. This further helps user with their developmental strategy.

This report examines all the key factors influencing growth of global HIV Drugs market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global HIV Drugs market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, scope of NPD in new markets, pricing strategies, innovation possibilities and much more.

Click Here to Get Free Sample Copy of HIV Drugs Market Report @ https://healthcaremarketreports.com/sample-request/hiv-drugs-market/7171/?utm_source=Chiatali&utm_medium=Free

Market Segment as follows:

By Region

Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]

Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

North America[United States, Canada, Mexico]

Middle East & Africa[GCC, North Africa, South Africa]

South America[Brazil, Argentina, Columbia, Chile, Peru]

Key Companies

Bristol-Myers Squibb

Gilead Sciences

GlaxoSmithKline

Johnson & Johnson

Merck

Market by Type

Other

Nucleoside Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors

Protease Inhibitors

Fusion Inhibitors

Entry Inhibitors - CCR5 Co-Receptor Antagonist

HIV Integrase Strand Transfer Inhibitors

Market by Application

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Others

The HIV Drugs market is amplifying at a CAGR and is projected to showcase higher growth trends in the ensuing years. The industry encompasses numerous primary sections such as medical equipment, pharmaceuticals and drugs, healthcare services and facilities, and hospital supplies. Our report is integrated with the comprehensive outlook of all the listed areas pertaining to the market.

HIV Drugs Market: Regional analysis includes

Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Europe (Turkey, Germany, Russia UK, Italy, France, etc.)

North America (the United States, Mexico, and Canada.)

South America (Brazil etc.)

The Middle East and Africa (GCC Countries and Egypt)

Some Points from Table of Contents

Chapter 1 HIV Drugs Introduction and Market Overview

Chapter 2 Executive Summary

Chapter 3 Industry Chain Analysis

Chapter 4 Global HIV Drugs Market, by Type

Chapter 5 HIV Drugs Market, by Application

Chapter 6 Global HIV Drugs Market Analysis by Regions

Chapter 7 North America HIV Drugs Market Analysis by Countries

Chapter 8 Europe HIV Drugs Market Analysis by Countries

Chapter 9 Asia Pacific HIV Drugs Market Analysis by Countries

Chapter 10 Middle East and Africa HIV Drugs Market Analysis by Countries

Chapter 11 South America HIV Drugs Market Analysis by Countries

Chapter 12 Competitive Landscape

Chapter 13 Industry Outlook

Chapter 14 Global HIV Drugs Market Forecast

Chapter 15 New Project Feasibility Analysis

Direct Purchase HIV Drugs Market Research Report Now @ https://healthcaremarketreports.com/purchase/hiv-drugs-market/7171/;utm_source=Chiatali&utm_medium=Free

Report includes Competitor's Landscape:

➊ Major trends and growth projections by region and country ➋ Key winning strategies followed by the competitors ➌ Who are the key competitors in this industry? ➍ What shall be the potential of this industry over the forecast tenure? ➎ What are the factors propelling the demand for the HIV Drugs? ➏ What are the opportunities that shall aid in significant proliferation of the market growth? ➐ What are the regional and country wise regulations that shall either hamper or boost the demand for HIV Drugs? ➑ How has the covid-19 impacted the growth of the market? ➒ Has the supply chain disruption caused changes in the entire value chain?

Healthcare Market Reports 99 Wall Street 2124 New York, NY 10005 US Contact No: +1(929)-450-2887 Email: [email protected]

Thanks for reading this article you can also get individual chapter wise section or region wise report version like North America, Europe, MEA or Asia Pacific.

#HIV Drugs Market

0 notes

priyanshisingh · 1 year ago

Text

Molecular Biology Enzymes Kits and Reagents Market Size, Industry Share, Growth Demand, Supply Chain, Trends Future Outlook, Forecast 2030

The latest market report published by Credence Research, Inc. “Global Molecular Biology Enzymes Kits and Reagents Market: Growth, Future Prospects, and Competitive Analysis, 2016 – 2028. The global Molecular biology enzymes kits and reagents market has witnessed steady growth in recent years and is expected to grow at a CAGR of 9.50% between 2023 and 2030. The market was valued at USD 20.2 billion in 2022 and is expected to reach USD 38.12854245 billion in 2030.

The molecular biology sector, long perceived as the backbone of biomedical science, has undergone significant advancements in recent years. Aiding in these developments, enzymes, kits, and reagents stand as crucial components. As a leading organization committed to innovation and research, we delve into an in-depth exploration of this domain, examining its current dynamics and projected growth.

Molecular Biology Enzymes Kits and Reagents Market Drivers refer to the various factors that propel the growth of this particular market segment. These drivers primarily include advancements in technology, where innovative techniques are constantly being developed to enhance the efficiency and accuracy of molecular biology experiments. Additionally, increasing funding for research and development activities has led to a surge in demand for high-quality enzymes kits and reagents, thus driving market growth. The expanding applications of molecular biology enzymes in fields such as diagnostics, drug discovery, forensic sciences, and agriculture have also significantly contributed to market expansion.

Applications in DNA Sequencing and Replication

Enzymes, such as DNA polymerases and ligases, play pivotal roles in DNA replication and sequencing. Their precision and efficiency are paramount to accurate genetic information transfer and interpretation.

Emerging Enzyme Technologies

As technology evolves, novel enzyme variants and synthetic enzymes are being introduced. These advancements are pushing the boundaries of what's achievable, ensuring the molecular biology community remains at the cutting edge of biomedical research.

Harnessing the Power of Molecular Biology Kits

Kits offer a standardized solution, ensuring consistency in results across laboratories worldwide. These kits encompass everything from DNA extraction to protein purification, providing a streamlined approach to molecular biology procedures.

Personalized Medicine and Kits

With the rise of personalized medicine, molecular biology kits tailored to individual patient needs are emerging. This specificity aids in accurate diagnosis, prognosis, and treatment options.

Browse 190 pages report Molecular Biology Enzymes Kits and Reagents Market By Product (Kits & Reagents, Enzymes, Ligases, Restriction Endonucleases, Reverse Transcriptases, Other Enzymes) By Applications (PCR, Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology, Other) - Growth, Future Prospects & Competitive Analysis, 2016 – 2030)- https://www.credenceresearch.com/report/molecular-biology-enzymes-kits-and-reagents-market

Reagents: The Unsung Heroes

Reagents act as reactants or substances used to detect, measure, or synthesize another substance. Their diverse range, from antibodies to dyes, plays a pivotal role in various molecular biology protocols.

Advancements in Reagent Technologies

Modern reagents are increasingly sensitive, precise, and reliable. Innovations in this sphere are enabling more intricate molecular studies and experiments.

Anticipated Market Growth and Key Drivers

The demand for molecular biology enzymes, kits, and reagents is on an upward trajectory. Key drivers include:

Increased R&D Activities: As biomedical research intensifies, the demand for these tools escalates.

Rise in Genetic Testing: With genetic disorders and diseases gaining attention, there's an uptick in testing, bolstering the market.

Pharmaceutical Industry Expansion: The burgeoning pharmaceutical sector continually seeks out these components for drug development and testing.

Why to Buy This Report-

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

Browse Full Report: https://www.credenceresearch.com/report/molecular-biology-enzymes-kits-and-reagents-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/urethral-bulking-systems-market

Related Report: https://www.credenceresearch.com/report/breast-lesion-localization-methods-market

Browse our Blog: https://www.linkedin.com/pulse/molecular-biology-enzymes-kits-reagents-market-rising-priyanshi-singh

Browse Our Blog: https://medium.com/@priyanshi_97937/molecular-biology-enzymes-kits-and-reagents-market-size-expected-to-acquire-usd-12-3-57dfd6643009

About Us -

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

0 notes

healthcare-market · 3 years ago

Text

Hepatitis Therapeutics Market Estimated to Record Highest CAGR by 2026

Transparency Market Research (TMR) has published a new report titled ‘Hepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global hepatitis therapeutics market was valued at US$ 22,049.2 Mn in 2017 and is projected to expand at a CAGR of 2.3% during forecast period from 2018 to 2026. The global market is anticipated to be driven by a rise in viraemic prevalence, promising pipeline of hepatitis drugs, and supportive government initiatives encouraging patients in the adoption of hepatitis drugs. The hepatitis therapeutics market in Asia Pacific is expected to expand at a high CAGR of 3.0%, due to a high incidence of hepatitis in emerging countries such as India and China and presence of local players providing a wide range of generic hepatitis drugs in the region.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=52665

Increase in Prevalence of Viral Hepatitis Drives Market

Hepatitis is a significant public health concern across the globe. According to the World Health Organization (WHO), in 2015, approximately, 257 million people globally, or 3.5% of the population, were living with chronic hepatitis B infections. Rise in the consumption of alcohol, infections from contaminated blood sources, and increase in the number of autoimmune diseases are leading to a rise in the cases of inflammation of the liver. Viral hepatitis is an important source of morbidity and mortality globally. As per WHO estimates, viral hepatitis caused 1.34 million deaths in 2015, a number higher than the deaths caused by HIV. Additionally, mortality associated with viral hepatitis has increased by 22% since 2000, and the number is further expected to increase over the next few years. Hence, these factors are likely to boost demand for hepatitis therapeutics over the forecast period.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52665

Hepatitis C Segment Dominated the Market

In terms of disease type, the global hepatitis therapeutics market has been classified into hepatitis A, hepatitis B, hepatitis C, and others. The hepatitis C segment is projected to account for a leading share of the global market during the forecast period, owing to the high prevalence of hepatitis C in developing and developed regions and availability of effective drug regimens in the market. According to the World Health Organization (WHO), approximately 71 million people were infected with chronic hepatitis C in 2017. Hepatitis C increases the risk of liver cirrhosis and is the leading cause of liver transplant in North America and Europe. Development of advanced therapeutics by leading industry players for the effective management of disease is expected to pave the way for the hepatitis C segment over the coming years. The hepatitis B segment is projected to expand at a rapid pace over the forecast period, owing to a high mortality rate associated with hepatitis B.

Request for Analysis of COVID19 Impact on Hepatitis Therapeutics Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=52665

Multi-class Combination to be the Most Promising Segment to Invest in

Based on drug class, the global hepatitis therapeutics market has been segmented into NS5A inhibitors, nucleotide analog reverse transcriptase inhibitors, multi-class combination, nucleotide analog NS5B polymerase inhibitors, interferon & ribavirin, and others. The multi-class combination segment is projected to expand at a high CAGR during the forecast period, owing to an increase in viraemic prevalence worldwide. Industry players are focused on developing combinational therapy as it is highly effective and has fewer side-effects compared to a single regimen for the treatment of hepatitis C. Mavyret and Epclusa are some of the combinational therapeutics recently approved by the U.S. FDA.

Asia Pacific Market to Witness Strong Growth and Create High Incremental Opportunity

In terms of region, the global hepatitis therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to account for a leading share of the global market during the forecast period, owing to high awareness and access to advanced hepatitis therapeutics and high affordability of patients in the region. The hepatitis therapeutics market in Europe is expected to expand at a substantial rate between 2018 and 2026. The market in Asia Pacific is likely to expand at a rapid pace in the next few years. This is attributed to a growing patient population, increasing penetration of global manufacturers, and rising government initiatives to promote disease awareness in the region. The hepatitis therapeutics market in Latin America and Middle East & Africa is anticipated to expand at a steady pace from 2018 to 2026.

Enquiry before Buying Hepatitis Therapeutics Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=52665

Growth Strategies by Key Market Players

Key players profiled in this report are Merck & Co., Inc., Gilead Sciences, Inc., AbbVie Inc., Bristol Myers Squibb, F. Hoffmann-La Roche, Ltd., LAURUS Labs, Zydus Cadila, Hetero Healthcare Limited, NATCO Pharma Limited, and Cipla, Inc. Companies operating in the global hepatitis therapeutics market focus on R&D to develop innovative drugs used for the effective treatment of hepatitis. Market players also resort to strategic collaborations and license agreements with domestic players to expand their market foothold in developing countries.

More Trending Reports by Transparency Market Research:

About Us Section:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!

Rohit Bhisey Transparency Market Research, 90 State Street, Suite 700, Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: [email protected]

Website: https://www.transparencymarketresearch.com/

0 notes

healthcaredbmrnews · 3 years ago

Text

Molecular Diagnostics Market Overview, Growth Analysis, Share, Opportunities, Sales, Trends, Supply, Forecast To 2028

Molecular Diagnostics Market research report assists business in every sphere of trade to take superior decisions, to tackle the toughest business questions and diminish the risk of failure. What is more, emerging product trends, major drivers, challenges and opportunities in the market are recognized and analysed factually while generating this report. Market drivers and market restraints mentioned in this Molecular Diagnostics report help businesses gain an idea about the production strategy. Market shares of these key players in the major areas of the globe such as Europe, North America, Asia Pacific, South America, Middle East and Africa are also studied.

The molecular diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.0% in the forecast period of 2021 to 2028 and is expected to reach USD 46,505.12 million by 2028. The demand for molecular diagnostics tools is increasing to diagnose COVID-19 patients, coupled with an increase in infectious disease and cancer prevalence as driver for the molecular diagnostics market growth.

Molecular diagnosis identifies or diagnoses diseases such as infectious diseases, genetic diseases, cardiovascular diseases, neurological diseases, and others by studying molecules such as DNA, RNA, protein in a tissue or a fluid. Different technologies such as PCR, mass spectrometry, next-generation sequencing, cytogenetics, in situ hybridization, molecular imaging, and others are used to diagnose different diseases. Molecular diagnostics use powerful tools such as gene expression profiling, DNA sequence analysis, and detection of biomarkers to determine the susceptibility of individuals to certain diseases or existing disease stage.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-molecular-diagnostics-market

The molecular diagnostics Market is segmented on the based on the products, technology, application and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

On the basis of products, the global molecular diagnostics market is segmented into reagents & kits, instruments and services & softwares. Instruments are further segmented into fully automated instruments and semi-automated instruments. In 2021, the instruments segment is expected to dominate the molecular diagnostics market due to the rise in demand for advanced technology to diagnose diseases such as infectious diseases, cancer, and others.

On the basis of technology, the global molecular diagnostics market is segmented into mass spectrometry (MS), capillary electrophoresis, next generation sequencing (NGS), chips and microarray, polymerase chain reaction (PCR)-based methods, cytogenetics, in situ hybridization (ISH or FISH), molecular imaging and others. The polymerase chain reaction (PCR)-based methods are further segmented into cold PCR, digital PCR, directlinear analysis, quantitative fluorescent PCR, real-time PCR and reverse transcriptase PCR. The molecular imaging segment is further subdivided into optical imaging and FDG-PET. In 2021, the polymerase chain reaction (PCR)-based methods segment is expected to dominate the molecular diagnostics market due to increased demand for PCR kits to diagnose COVID-19 and curb the pandemic.

On the basis of application, the global molecular diagnostics market is segmented into oncology, pharmacogenomics, microbiology, prenatal tests, tissue typing, blood screening, cardiovascular diseases, neurological diseases, infectious diseases and others. The oncology segment is further segmented into oncology, by cancer type and oncology, by technology. The oncology, by cancer type is further sub-divided into breast cancer, colorectal cancer, lung cancer, prostate cancer and others. The oncology, by technology is further sub-segmented into mass spectrometry (MS), capillary electrophoresis, next generation sequencing (NGS), chips and microarray, polymerase chain reaction (PCR)-based methods, cytogenetics, in situ hybridization (ISH or FISH), molecular imaging and others.

The blood screening is further segmented into mass spectrometry (MS), capillary electrophoresis, next generation sequencing (NGS), chips and microarray, polymerase chain reaction (PCR)-based methods, cytogenetics, in situ hybridization (ISH or FISH), molecular imaging and others. The cardiovascular diseases are further segmented into mass spectrometry (MS), capillary electrophoresis, next generation sequencing (NGS), chips and microarray, polymerase chain reaction (PCR)-based methods, cytogenetics, in situ hybridization (ISH or FISH), molecular imaging and others.

On the basis of end user, the global molecular diagnostics market is segmented into hospital, clinical laboratories and academics. In 2021, the clinical laboratories segment is expected to dominate the molecular diagnostics market due to the rising number of patients with various illnesses and the growing need for diagnostics instruments.

Attractions of the Molecular Diagnostics Market Report: -

Latest market dynamics, development trends and growth opportunities are presented along with industry barriers, developmental threats and risk factors

The forecast Molecular Diagnostics Market data will help in the feasibility analysis, market size estimation and development

The report serves as a complete guide which micro monitors all vital Molecular Diagnostics Market

A concise market view will provide ease of understanding.

Molecular Diagnostics Competitive market view will help the players in making a right move

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-molecular-diagnostics-market

Table of Content:

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Global Molecular Diagnostics Market Landscape

Part 04: Global Molecular Diagnostics Market Sizing

Part 05: Global Molecular Diagnostics Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

New Business Strategies, Challenges & Policies are mentioned, Request for Detailed TOC at https://www.databridgemarketresearch.com/toc/?dbmr=global-molecular-diagnostics-market

Key Questions Answered

What impact does COVID-19 have made on Global Molecular Diagnostics Market Growth & Sizing?

Who are the Leading key players and what are their Key Business plans in the Global Molecular Diagnostics Market?

What are the key concerns of the five forces analysis of the Global Molecular Diagnostics Market?

What are different prospects and threats faced by the dealers in the Global Molecular Diagnostics Market?

What are the strengths and weaknesses of the key vendors?

Reasons to Purchase this Report:

Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects

Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.

Market value USD Million and volume Units Million data for each segment and sub-segment

Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years

Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

The major companies which are dealing in the Molecular diagnostics are Abbott, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., BD, bioMérieux SA, Cepheid, Hologic, Inc., Life Technologies, Myriad Genetics, Inc., QIAGEN, Agilent Technologies, Inc., Quidel Corporation, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., IMMUCOR, Luminex Corporation, Meridian Bioscience, Hoffmann-La Roche Ltd, and GenMark Diagnostics, Inc. among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Trending Related Reports:

Fitness App Market

Healthcare Interoperability Solutions Market

Health Tourism Market

Hospital Asset Management Market

HPV Testing & Pap test Market

Hysteroscopy Instruments Market

Interoperable Healthcare Solutions Market

Laboratory Information Management Systems Market

Lithotripsy Devices Market

Long Term Care Software Market

#Molecular Diagnostics Market

0 notes

marketresearchindia · 3 years ago

Text

Rise in Prevalence of Influenza and Related Chronic Diseases Expected to Drive Global Influenza Diagnostic Equipment Market: Ken Research

Buy Now

Influenza is acknowledged as a critical cause of morbidity & mortality in the human population that leads to the development and use of diagnoses to reduce the consequences of health & economic impact. Influenza Diagnostic Equipment is a specific type medical device that helps in the procedure of diagnosing patients who are suffering from influenza. Reverse transcription-polymerase chain reaction (RT-PCR), influenza diagnostic tests, cell culture, and others are few of the most common types used for this purpose. Influenza Diagnostic Equipment enables early detection of a pandemic to prevent widespread spread & death. Influenza Diagnostic Equipment is used in hospitals, clinics, laboratories, or even from home.

Referring to the study, Global Influenza Diagnostic Equipment Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027. Some of the key companies operating in the global influenza diagnostic equipment market include Thermo Fisher Scientific, BD Medical, DiaSorin, Alere Inc., SA Scientific, Quidel Corporation, Abbott laboratories, Luminex Corporation, Roche Diagnostics, Sekisui Diagnostics and among others.

Based on types, influenza diagnostic equipment market can be segmented as Reverse transcription polymerase chain reaction (RT-PCR), Influenza diagnostic tests (RIDT), cell culture and others. With the RT-PCR method, RNA of the flu-virus is imitative into DNA using a reverse transcriptase enzyme and then multiplied by another enzyme recognized as Polymerase-Chain Reaction. This process is repeated several times in order to amplify the original sample for easy identification. RIDTs are special types of immunoassays that assist to identify the occurrence of influenza-A and influenza-B viral nucleoprotein antigens in the respiratory samples and also provide qualitative results. RIDT segment is expected to exhibit higher CAGR due to their common usage in point-of-care settings during the forecast period. Additionally, cell culture is the process of proliferation of cells that have been isolated from primary tissues or other established cell lines under special conditions. In addition, based on applications, market can be segregated as POTC, hospital and laboratories.

Request For Sample Report-https://kenresearch.com/sample-report.php?Frmdetails=NDQ0NTY0

Rise in demand for early diagnosis and control of influenza, followed by increase in government initiatives towards vaccination programs, growth in aging population in developed nations, increase in research funding for influenza diagnostics and rise in prevalence of influenza and related chronic diseases are some major factors, which are responsible for growth of the influenza diagnostic equipment market. Apart from this, strict FDA regulations may impact the market.

Based on regional analysis, the North-America is a leading region in global influenza diagnostic equipment market owing to increase in focus on preventive healthcare measures and rapid urbanization across developing countries in the region. The Asia-Pacific and Europe regions are estimated to witness higher growth rate due to increase in government investments in public health infrastructure, rise in prevalence of acute respiratory diseases and increase in awareness regarding benefits associated with early disease diagnostics over the forecast period. It is projected that future of the global influenza diagnostic equipment market will be bright on account of growth in healthcare expenditure coupled with increase in number of influenza outbreaks during the forecast period.

For More Information, refer to below link:-

Global Influenza Diagnostic Equipment Market Research Report

Related Reports

2021-2027 Global and Regional Varicella Vaccine Industry Status and Prospects Professional Market Research Report Standard Version

2021-2027 Global and Regional Medical Gas Analyzers Industry Status and Prospects Professional Market Research Report Standard Version

LinkedIn | Instagram | Facebook | Twitter | YouTube

Ken Research

Ankur Gupta, Head Marketing & Communications

[email protected]

#marketresearch #marketresearchreports #industrynews

0 notes